NO920853L - Fremgangsmaate for hurtig radioaktiv merking av monovalente antistoff-fragmenter med technetium - Google Patents

Fremgangsmaate for hurtig radioaktiv merking av monovalente antistoff-fragmenter med technetium

Info

Publication number
NO920853L
NO920853L NO92920853A NO920853A NO920853L NO 920853 L NO920853 L NO 920853L NO 92920853 A NO92920853 A NO 92920853A NO 920853 A NO920853 A NO 920853A NO 920853 L NO920853 L NO 920853L
Authority
NO
Norway
Prior art keywords
monovalent antibody
antibody fragment
technetium
quick
procedure
Prior art date
Application number
NO92920853A
Other languages
English (en)
Other versions
NO920853D0 (no
Inventor
Hans J Hansen
Anastasia Lentine-Jones
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Publication of NO920853L publication Critical patent/NO920853L/no
Publication of NO920853D0 publication Critical patent/NO920853D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO92920853A 1989-09-18 1992-03-04 Fremgangsmaate for hurtig radioaktiv merking av monovalente antistoff-fragmenter med technetium NO920853D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40824189A 1989-09-18 1989-09-18
PCT/US1990/005196 WO1991004056A1 (en) 1989-09-18 1990-09-18 Method for rapidly radiolabeling monovalent antibody fragments with technetium

Publications (2)

Publication Number Publication Date
NO920853L true NO920853L (no) 1992-03-04
NO920853D0 NO920853D0 (no) 1992-03-04

Family

ID=23615452

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920853A NO920853D0 (no) 1989-09-18 1992-03-04 Fremgangsmaate for hurtig radioaktiv merking av monovalente antistoff-fragmenter med technetium

Country Status (15)

Country Link
EP (1) EP0419203B1 (no)
JP (1) JPH0723326B2 (no)
KR (1) KR960015611B1 (no)
AT (1) ATE110281T1 (no)
AU (1) AU640698B2 (no)
CA (1) CA1340250C (no)
DE (1) DE69011789T2 (no)
DK (1) DK0419203T3 (no)
ES (1) ES2063286T3 (no)
FI (1) FI921146A0 (no)
IE (1) IE64399B1 (no)
IL (1) IL95723A (no)
NO (1) NO920853D0 (no)
WO (1) WO1991004056A1 (no)
ZA (1) ZA907420B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460785A (en) * 1989-08-09 1995-10-24 Rhomed Incorporated Direct labeling of antibodies and other protein with metal ions
US5346687A (en) * 1989-08-09 1994-09-13 Rhomed Incorporated Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
EP0498333B1 (de) * 1991-02-05 1997-01-15 Cis Bio International Verfahren zur Herstellung einer mit Technetium-99m markierten organspezifischen Substanz
CA2104943A1 (en) * 1991-02-27 1992-08-28 Ramaswamy Subramanian Technetium-99m labeling of proteins
ZA955642B (en) * 1994-07-07 1997-05-06 Ortho Pharma Corp Lyophilized imaging agent formulation
US5942210A (en) * 1994-11-15 1999-08-24 Cytogen Corporation Methods for lyoprotecting a macromolecule using tricine
US6080384A (en) * 1997-03-25 2000-06-27 American Biogenetic Sciences, Inc. Methods for radionuclide-labeling of biomolecules and kits utilizing the same
WO1999012579A1 (en) * 1997-09-08 1999-03-18 The General Hospital Corporation Imaging agents for early detection and monitoring of cardiovascular plaque
US7060251B1 (en) 1997-09-08 2006-06-13 The General Hospital Corporation Imaging agents for early detection and monitoring of cardiovascular plaque
EP1419786A1 (en) * 2002-11-13 2004-05-19 Bracco Imaging S.p.A. Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof
ITMI20022411A1 (it) * 2002-11-14 2004-05-15 Bracco Imaging Spa Agenti per la diagnosi e la terapia di tumori che espongono sulla superficie delle cellule proteine alterate.
US7229603B2 (en) * 2004-06-17 2007-06-12 Anazaohealth Corporation Stablilized and lyophilized radiopharmaceutical agents
US20070248533A1 (en) * 2004-06-17 2007-10-25 Kuperus John H Stabilized and Lyophilized Radiopharmaceutical Agents For Destroying Tumors
KR20080022108A (ko) * 2005-06-14 2008-03-10 니혼 메디피직스 가부시키가이샤 방사성 화상 진단제

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725295A (en) * 1971-07-20 1973-04-03 Atomic Energy Commission Technetium labeling
US4057617A (en) * 1975-05-15 1977-11-08 Abramovici J Method of labeling proteins with technetium
US4062933A (en) * 1975-05-27 1977-12-13 Mallinckrodt, Inc. Colloidal compositions with protective agents suitable for radioactive labeling
US4323546A (en) * 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4293537A (en) * 1978-09-05 1981-10-06 Wong Dennis W Novel chemical method of labeling proteins with 99m Tc-Technetium at physiological condition
US4472371A (en) * 1979-10-29 1984-09-18 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
USRE32417E (en) * 1979-10-29 1987-05-12 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4401647A (en) * 1980-03-03 1983-08-30 The Regents Of The University Of Ca Radiolabeled neoglycopeptides
US4500507A (en) * 1981-10-30 1985-02-19 Wong Dennis W Diagnostic composition for radiologic imaging of neoplasms in the body and method of preparation
JPS5967228A (ja) * 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
WO1988007382A2 (en) * 1987-04-02 1988-10-06 Centocor Cardiovascular Imaging Partners, L.P. Method for labelling antibodies with a metal ion
US5061641A (en) * 1988-04-01 1991-10-29 Immunomedics, Inc. Method for radiolabeling proteins

Also Published As

Publication number Publication date
FI921146A7 (fi) 1992-03-17
CA1340250C (en) 1998-12-15
ATE110281T1 (de) 1994-09-15
ZA907420B (en) 1991-07-31
AU640698B2 (en) 1993-09-02
JPH04505455A (ja) 1992-09-24
JPH0723326B2 (ja) 1995-03-15
IL95723A0 (en) 1991-06-30
WO1991004056A1 (en) 1991-04-04
DE69011789D1 (de) 1994-09-29
AU6521490A (en) 1991-04-18
DK0419203T3 (da) 1994-12-05
ES2063286T3 (es) 1995-01-01
KR920703111A (ko) 1992-12-17
FI921146L (fi) 1992-03-17
EP0419203A1 (en) 1991-03-27
IE64399B1 (en) 1995-08-09
IE903360A1 (en) 1991-04-10
IL95723A (en) 1995-08-31
NO920853D0 (no) 1992-03-04
KR960015611B1 (ko) 1996-11-18
DE69011789T2 (de) 1994-12-15
EP0419203B1 (en) 1994-08-24
FI921146A0 (fi) 1992-03-17

Similar Documents

Publication Publication Date Title
NO920853D0 (no) Fremgangsmaate for hurtig radioaktiv merking av monovalente antistoff-fragmenter med technetium
ATE247985T1 (de) Einführung einer thiol-gruppe in proteine für die radioimmundetektion und radioimmuntherapie auf der basis von radionukliden
BR9107074A (pt) Imunorreagente radioativo de marcacao,composicao e processo de formacao de imagem diagnostica,composicao terapeutica,processo de tratamentod e silios doentios e composicao da materia
NO951592L (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system
DE69014137D1 (de) Immunogenische Zusammensetzungen gegen Gastrin-Peptide.
SE9002522D0 (sv) Metod foer framstaellning av en farmaceutisk komposition i form av mikropartiklar
NO883926L (no) Fremgangsmaate for fremstilling av stabilisert humanproteinpreparat.
ATE79283T1 (de) Injektionsgeraet mit einem spannglied und mit einem zweiten stellglied.
NZ217570A (en) Antibody complexes of hapten modified diagnostic or therapeutic agents
ATE240748T1 (de) Zusammensetzung zur sichtbarmachung von blutstauungen und ihre anwendungsmethoden
DE3783745D1 (de) Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz.
FR2297034B1 (no)
FI950771L (fi) Menetelmä renium-188:n ja teknetium-99:n kehittimien valmistamiseksi
ATE88129T1 (de) Verfahren zur herstellung von aus kueken und gehaeuse bestehendem haehnchen fuer medizinische geraete.
ATE254481T1 (de) Radioaktiven chitosankomplex und deren anwendung in strahlungstherapie
ATE186550T1 (de) Verbindungen und pharmazeutische zusammensetzungen zum nachweis und zur lokalisierung von geweben mit neurokinin-1- rezeptoren
DE3688204D1 (de) Monoklonaler antikoerper gegen ein p21-bezuegliches dodekapeptid des ras-onkogens.
DK325289A (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
PL264490A1 (en) Method of enhancing lactiferous gland parenchyma growth and drug therefor
PT90296A (pt) Processo para a preparacao de anticorpos monoclonais contra pseudomonas aeruginosa e de composicoes farmaceuticas que os contem
GB8704648D0 (en) Antibodies
FI96742C (fi) Minoksidiilia sisältävä 1-faasigeelikoostumus ja menetelmä sen valmistamiseksi
KR900018678A (ko) 엘라스타제-1의 면역 분석법
DE69008859D1 (de) Modifizierte menschliche anti-rh(d)-antikörper.
FI924577A7 (fi) Menetelmä 1,2,4-trifluoribentseenin ja 1-kloori-3,4-difluoribentseenin valmistamiseksi